Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Benitec Biopharma Ltd (BNTC)

2.59   -0.32 (-11%) 03-05 08:52
Open: 2.93 Pre. Close: 2.91
High: 3.02 Low: 2.52
Volume: 442,586 Market Cap: 12M
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.026 - 3.043 3.043 - 3.062
Low: 2.479 - 2.495 2.495 - 2.513
Close: 2.559 - 2.588 2.588 - 2.619

Technical analysis

as of: 2021-03-05 8:07:43 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.22     One year: 6.62
Support: Support1: 2.52    Support2: 2.10
Resistance: Resistance1: 4.47    Resistance2: 5.67
Pivot: 3.98
Moving Average: MA(5): 2.93     MA(20): 4.14
MA(100): 3.34     MA(250): 5.59
MACD: MACD(12,26): -0.32     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 4.18     %D(3): 4.39
RSI: RSI(14): 31.19
52-week: High: 17.39  Low: 2.52  Change(%): -65.5
Average Vol(K): 3-Month: 58446  10-Days: 51685

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
BNTC has closed above bottom band by 11.1%. Bollinger Bands are 183.8% wider than normal. The large width of the bands suggest high volatility as compared to BNTC's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Tue, 02 Mar 2021
Should You Accumulate Benitec Biopharma Inc (BNTC) Stock Tuesday? - InvestorsObserver

Wed, 24 Feb 2021
Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies - Benzinga

Wed, 24 Feb 2021
Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study - Yahoo Finance

Wed, 27 Jan 2021
Can Benitec Biopharma (NASDAQ:BNTC) Afford To Invest In Growth? - Simply Wall St

Tue, 26 Jan 2021
Benitec Biopharma Inc (BNTC) Stock: What Does the Chart Say? - InvestorsObserver

Mon, 07 Dec 2020
Benitec Biopharma Announces 2020 Annual Stockholder Meeting - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 4
Shares Float (M) 3
% Held by Insiders 16.04
% Held by Institutions 9.17
Shares Short (K) 18
Shares Short P. Month (K) 7

Stock Financials

EPS -9.086
EPS Est This Year -0.100
EPS Est Next Year -0.240
Book Value (p.s.) 6.980
Profit Margin
Operating Margin -7907.26
Return on Assets (ttm) -49.8
Return on Equity (ttm) -80.9
Qtrly Rev. Growth 66.7
Gross Profit (p.s.) 0.065
Sales Per Share 0.028
EBITDA (p.s.) -2.181
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -0.29
PEG Ratio
Price to Book value 0.37
Price to Sales 92.11
Price to Cash Flow -1.22

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2018-06-07
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.